SEC Form 6-K filed by InMode Ltd.
$INMD
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2024
INMODE LTD.
(Exact name of registrant as specified in its charter)
Tavor Building, Sha’ar Yokneam
P.O. Box 533
Yokneam 2069206 Israel
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
|
Form 20-F ☒ Form 40-F ☐
|
Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934:
|
Yes ☐ No ☒
|
On February 13, 2024, InMode Ltd. (the “Company”) announced that it will hold its Annual General Meeting of the Shareholders of the Company on Monday, April 1,
2024, beginning at 17:00, Israel time, at the offices of the Company located at Tavor Building, Sha’ar Yokneam Industrial Park, Yokneam, Israel. A copy of the proxy statement is attached hereto as Exhibit 99.1.
|
Exhibit No.
|
Description of Exhibit
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
InMode Ltd.
|
|
|
By:/s/ Moshe Mizrahy
|
|
|
Moshe Mizrahy
|
|
|
Chief Executive Officer and Chairman of
The Board of Directors
|
Dated February 13, 2024